Search results

ACBio delivers marketing & communications strategies, content, and brand narratives to life science companies worldwide to help them gain market leadership. We blend PhD-level scientific knowledge with effective marketing tactics to translate complex tech into understandable value for stakeholders.

Hettich AG, based in Bäch, Switzerland, has supplied laboratory equipment since 1977. We develop and distribute Hettich instruments and represent Memmert, Helmer, B Medical Systems and delta T, supporting life science customers with expertise, reliability and local service.

Headquartered in Switzerland with global operations, Space Peptides provides end-to-end pharmaceutical Peptide CRDMO services - covering discovery, process development, and GMP manufacturing. In addition, our portfolio comprises a broad range of generic Peptide APIs.

Stallergenes Greer is a fully integrated global healthcare company specialising in the research, diagnosis and treatment of allergies through the development and commercialisation of allergen immunotherapy (AIT) products and services.

RC TRITEC is an established company offering custom synthesis of tritium-labeled compounds, a range of tritiated catalog products, storage service and disposal of radiochemicals. We have over 60 years of experience in the safe handling of tritium gas using in-house developed high-vacuum equipment.

Macrogen Europe GmbH, Swiss branch of Macrogen Europe B.V. (Amsterdam), provides fast, reliable Sanger and NGS sequencing. All sequencing labs are based in Amsterdam and Seoul. We support research and clinical needs across Europe and Africa with advanced genomic and bioinformatics services.

We develop animal-based products via cell cultivation, combining proprietary animal cell biology with scalable bioprocessing at favorable unit economics. The platform starts with the world's first cultivated whole-cut beef and expands into functional applications, like cell-derived collagen.

Axcura AG is a Swiss life-science company specializing in the sourcing, qualification, and distribution of pharma and biotech raw materials. We combine Swiss quality, regulatory excellence, and global supplier networks to secure reliable, compliant supply chains.

EVIIVE develops single extracellular vesicle-based diagnostics to predict immunotherapy response and monitor tumor microenvironment in real time. Our platform integrates advanced flow analytics and machine learning for precision oncology applications.

Parithera is pioneering an AI-ready, clinical-grade liquid biopsy platform for single-cell analysis. Our platform is ideally positioned to study cancer treatment resistance.

Devintec Pharma is focused on B2B partnerships through out-licensing innovative substance-based medical devices. We apply DevinPro™ technology, that addresses root causes and creates a protective barrier for lasting relief, to our patended products in gastroenterology, dermatology, and gynecology.

Philip Morris International (PMI) is a leading international tobacco company with the objective to replace cigarettes with smoke-free products. The goal is to offer adult smokers, who would otherwise continue to smoke, better alternatives that are scientifically substantiated.

OptoLumina is dedicated to advancing research and promoting the use of optogenetics through cutting-edge illumination technologies. Our flagship product, the Lumiplate, is evidence of our commitment to innovation and quality.

Juvion develops advanced therapeutics aimed at preserving neuron-muscle connectivity, tackling immobility and sarcopenia to extend healthspan.

BeOne Medicines is a global oncology company developing innovative, affordable, and accessible cancer treatments worldwide. We expedite development of our diverse pipeline of novel therapeutics through strong internal capabilities and collaborations. Our 11,000 colleagues span six continents.

The Nikon Microscope Solutions unit is focused on serving customers in research, biotech/pharma, the clinical laboratory, and academia with industry leading microscope-based imaging solutions. In addtion the Nikon BioImaging Lab, is a CRO that provides microscope-based imaging and analysis services.

ICE Biopharma has 2 core businesses: in-licensing specialty and rare disease drugs for Europe and Canada, and operational consultancy to companies evaluating international Commercialization options. We want European and Canadian patients to have access to the breakthrough therapies they deserve.

Xcube.bio invests capital, knowledge and capabilities in the European market entry of late-stage biopharmas, with the objective to create partners' own commercial footprint and revenue streams. We offer a unique value proposition that open and de-risk the European market for innovative therapies.

APR Applied Pharma Research s.a. (wholly owned by Relief Therapeutics Holding AG, SIX: RLF.SW), is a B2B Swiss-based international biopharma focused on development and global commercialization of innovative, patent protected products designed to address unmet needs.

At Stämm we develop accessible, plug & play biomanufacture solutions; allowing an automatized, continuous and more efficient production of biologics and cell therapies while managing media conditions. We have reinvented biomanufacturing by providing an alternative to the known biomass production.

MaxWell Biosystems is an electronics-focused life-science company based in Zurich, Switzerland, developing and selling high-content electrophysiology platforms to help our customers in the pharmaceutical industry and in academia make their drug discovery and research more efficient.

At ATANIS Biotech AG, our mission is to revolutionize the way allergies are diagnosed and thereby to improve treatment success Our novel cell-based assay allows us to quantify patients allergic status with unparalleled diagnostic accuracy, without needing to expose patients to the culprit allergen.

Porton Pharma Solutions, a global company with R&D, and GMP-compliant manufacturing facilities across US, EU and China, provides customer-centric innovative, and reliable CDMO solutions for Small Molecules, Tides, Biologics and Conjugates (ADCs, PDCs, etc.) from pre-clinical to commercial stage.

iCure offers the Cardinal platform for developing digital health applications that comply with cybersecurity standards, with end-to-end encryption, FHIR interoperability, and open-source SDKs, accelerating innovation in e-health. iCure is ISO27001, ISO13485, HDS certified, GDPR and NIS2 compliant.

The Jackson Laboratory (JAX) is an independent, nonprofit biomedical research institute that has been at the forefront of translational research for over 90 years. Leveraging the strength of its research centers, JAX offers drug developers innovative preclinical platforms and services.

Blueprint Medicines is a global precision therapy company inventing life-changing therapies for people with cancer and blood disorders. Applying an approach that is both precise and agile, our medicines selectively target genetic drivers, with the goal of staying one step ahead of disease.

LabForce AG is a Swiss company, founded in January 1999. We have the largest portfolio of antibodies, proteins and assay kits in Switzerland accomplished by innovative and best-in-class laboratory equipment in the field of cellular and molecular biology.

Revolutionizing clinical trials, Trialize's cutting-edge automation platform accelerates study build times by 4x and curbs manual labor by up to 73%, enhancing data quality, patient adherence, and team morale. It's a game-changer in modern, decentralized, and virtual studies.

CELLnTEC technologies enable science and industry to develop innovations in stem cell research, regenerative medicine, cell-based therapies, and beyond. The company is a pioneering developer of chemically defined, animal and human components-free precision media.

Delta Medical, based in Zurich, specializes in pharmaceutical marketing, distribution, regulatory affairs, market access, and pharmacovigilance, serving Ukraine and Eurasian markets with tailored commercialization solutions and strategic partnerships.

Provectis Healthcare AG is a global healthcare company based in Basel and the commercial partner of choice to the innovative biopharma. We advance the innovation through launch, commercialization and brand building in Europe, Middle East and Asia.

Phialogics is a preclinical biotech company specialized in engineering next-generation biologics to rebalance the immune response in acute and chronic inflammation.

JMP empowers users to explore and analyze data visually, solve critical problems, and then share those insights to make stronger data-driven decisions. Unlike spreadsheets or other statistical software, JMP is designed for the way you solve problems across the entire analytic workflow.

MEDICE has always developed and produced medicinal products almost exclusively at the Iserlohn site and concentrates in the prescription area on CNS, renal medicine and dialysis medicine. Salmon Pharma is the Swiss subsidiary of MEDICE.

Pheida develops and deploys biotech solutions at scale to reduce GHG emissions and other pollutants, and to remediate contaminated soil and water. Pheida products combine advanced biotech, proprietary application engineering to deliver unique and commercially attractive solutions.

Tigen is a Swiss clinical stage biotech company developing cell therapies to cure cancer. A disruptive catalyst, combining a unique culture with a multidisciplinary set of world-class capabilities and a long-term perspective to accelerate access to novel T-cell therapies for patients and society.

iQone is a Swiss specialty pharma company for oncology, immunology and rare diseases. We commercialise innovative and biosimilar medicines with 7 marketed and 9 late-stage products. iQone can support partner products directly in the 5 major EU + CH markets, and indirectly in the rest of Europe. iQone Healthca

At Navignostics we characterize tumors using spatial single-cell proteomics. We use unique capabilities to identify a cancer treatment that will optimally fight a tumor. We accelerate cancer drug development by providing key insights into drug mechanisms and tumor features to pharma companies.

Elionova AG is a Swiss biotechnology company founded in September 2020. Headquartered in Fribourg, Elionova specializes in the development of cutting-edge immunodiagnostic solutions. Real-Time Immunoassays: Quantitative, Fast (10min to result), Simple (one step) using Disposables.

4bases is a company active in the fields of prevention and precision medicine. 4bases is a certified company working accordingly to the IVDR regulation. Our products are reagent kits for platform-independent New Generation DNA Sequencing (NGS), data analysis software and diagnostic protocols.

ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation.

Aspeya, owned by Philip Morris International, operates independently and utilizes Fertin Pharma's oral technology platform. Fertin Pharma, a wholly owned subsidiary of Aspeya, is a CDMO that develops and manufactures innovative oral and intra-oral delivery systems.

Risklick is shaping the future of clinical trial protocols by offering the first-of-its-kind, AI-based tool for developing high-quality clinical trial protocols and optimizing them efficiently, using historical data. We enable experts to develop high-quality protocols in a short time.

Lucerna Chem is one of the leading distributors for life science products in Switzerland, providing high quality reagents and kits from more than 70 suppliers for both research and diagnostics. We conveniently supply our customers with a variety of 4 Mio. products in simple domestic shipments.

Miltenyi Biotec Swiss AG is the local subsidiary of Miltenyi Biotec BV&Co KG (Germany). Miltenyi Biotec plays an important role in the design, development, manufacture, and integration of products that empower the advancement of biomedical research and enable cell and gene therapy.

MD Bioproducts, with over 30 years of experience, is a worldwide manufacturer and supplier of high-quality antibodies, reagents, peptides, assays, and disease-induction reagents supporting research in arthritis, autoimmune diseases, immunology, inflammation, neurology, metabolism, and oncology.

Aptissen is specialized in the development, distribution, and marketing of viscosupplements/orthobiologic solutions and drinkable food supplement in the area of joint health and soft tissue.

TissueLabs is a Swiss biotech pioneering biofabrication, developing 3D bioprinters, tissue-specific hydrogels, and engineered tissues. Supporting research, drug testing, and regenerative medicine, its long-term vision is to create the first transplantable bioartificial heart.

Limula is a Life Science Tools company based in Lausanne, Switzerland. We combine cell therapy process development and precision engineering to offer a fully closed and automated platform for the production of CAR-T and other highly-personalised treatments.

Healiva’s Wound Care & Skin Diseases proprietary Platform Technology includes an end-to-end approach with enzyme technology and cell therapies for wound care and skin diseases. The platform can diversify into vitiligo management, skin regeneration or sports injury applications.

At Alithea Genomics we develop, produce and commercialize cutting-edge solutions for drug and biomarker discovery based on gene expression. Our products provide high throughput and cost-efficiency, which is ideal for large-scale projects such as drug screening and biomarker discovery.

Labatec is a privately owned Swiss-based pharmaceutical company with more than 50 years of experience in delivering high quality products to the European and Emerging Markets. Covering both the hospital and retail sectors, we have a portfolio of over 65 products and a growing geographic footprint.

Novochizol SA researches and develops applications of Novochizol, a unique chitosan nanoparticle technology that yields different carriers of small molecules, peptides, nucleic acids and proteins for sustained, localized delivery to any living tissue, with intracellular targeting potential.

Ceidos is a Swiss biotech company developing the C-Netics, an innovative device for automated cell culture monitoring. Their mission is to optimize bioproduction processes for modern treatments through automation and innovative technologies.

OM Pharma is a global Geneva-based biopharmaceutical company. It is a leader in the prevention of recurrent respiratory and urinary tract infections, also active in the treatment of vascular diseases.

SOTIO is a biotech company building a diverse portfolio of oncology products through its own R&D, collaborations, in-licensing, investments, M&A. SOTIO is conducting multiple Phase I to III clinical trials targeting various types of cancer and has facilities in Europe and the US.

Cerdia, headquartered in Basel, is a pioneer in cellulose acetate tow since 1912 and a global quality and innovation leader of filter tow for cigarette manufacture. We are developing innovative applications and processes that will define Cellulose Acetate as a sustainable raw material in the future.

Debiopharm is an independent biopharmaceutical company based in Switzerland with an ongoing commitment to improve patient outcomes and quality of life in oncology and bacterial infections. Our main activities include drug development, drug manufacturing and digital health investment.

Artidis® is a pioneering clinical stage health technology company that aims to set the gold standard in tissue analysis and therapy optimization. Artidis focuses its efforts on solid tumors to enhance responses to chemo, immuno, and cell therapies, driving precision in cancer care.

abc biopply AG is pioneering NAM technologies and organoid CRO services that boost in vitro studies for drug discovery and development to IND relevance using its proprietary 3D CoSeedis Multi-Organoid in chip Technology™ on clinically relevant disease models (oncology, neurology, obesity and others).

There is a new kit on the block. Swiss start-up NEMIS Technologies AG specialises in the development of simple, safe, and on-site pathogen testing solutions. Its detection test for Listeria monocytogenes is already commercially available in Switzerland, France, and Spain.

SEED Biosciences is an award-winning company and an enabler of personalized medicine. We provide scientists with innovative single cell tools that are gentle with cells, affordable, intuitive and compliant with stringent regulatory demands.

Ectica Technologies supplies hydrogel-based tools to the biopharmaceutical and life science industries for drug discovery and bioresearch applications. Ectica Technologies manufactures and supplies the 3DProSeed product line for drug discovery and research in oncology, immuno-oncology and neurosciences. It en

Venture Valuation specializes in independent assessments and valuations of companies and products, in biotech and life sciences, and runs the business development database Biotechgate with global licensing deals, and opportunities. To learn more: www.biotechgate.com and Biotechgate Digital Partnering: www.dig

At UCB, we are inspired by patients and driven by science. Our strategy: to offer value to people suffering from severe diseases in neurology and immunology. In Switzerland, UCB invested around 700 million CHF in his plant for industrial equipment on the cutting edge of technology and innovation.

tiventa takes care for fresh air! Our mission is to clean the ventilation system in all kind of buildings, restaurants, industries, apartments and more. We are protecting people from airborne contaminants from entering room air and to maintain healthy indoor air quality.

Synple Chem was founded to develop new easy to use automated laboratory equipment for chemistry research labs.

Tepthera is a spin off from the ETH Zurich focusing on product development in the field of cancer immunotherapy, autoimmune- and infectious diseases.

SOPHiA GENETICS is the creator of a global data-sharing network – we work with customers from over 750 institutions in over 70 countries.  Our network advances data-driven medicine to improve health outcomes and economics worldwide.

QuartzBio SA is a Swiss data driven biomarker discovery and validation company and the trusted partner of companies and institutions for their in-silico biomarker discovery programmes. Leveraging a unique Biomarker Optimisation Software System – BOSS™ – we discover and validate biomarkers.

Socorex is a Swiss manufacturer of liquid handling instruments. Its programme includes high precision instruments used for reliably measuring, dosing, transferring and dispensing liquids, such as micropipettes and dispensers. Maintenance and calibration for all brands as well.

Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular and pulmonary diseases with high unmet medical need.

Securecell is an innovator for both the biotech and medtech space. Developing use-case applications for automated bioprocessing and smart pharmacoligical facilities, as well as the transformative applications of digital technologies to help hospitals and life scientists solve next-world problems.

Regen Lab is a global leader in products for autologous regenerative medicine based on freshly prepared platelet rich plasma from the patient’s own blood, used either alone or combination with hyaluronic acid or other fresh autologous cells from the patient’s fat or bone marrow.

As Swiss branch of Promega Corp, Promega AG offers local scientific expertise for 4000+ products covering genomics, proteomics and cell analysis. Promega is a global leader in providing innovative solutions for drug discovery, basic research, human identification, diagnostics and food/water testing.

Pall Biotech offers a blend of innovative traditional, single-use and continuous processing technologies and services to create scalable bioprocessing solutions. From concept through to design, validation and production, Pall leverages best-in class technologies for all bioprocessing applications. Pall (Schwe

PeptART manufactures a large variety of amino acid derivatives, pseudoprolines, and peptides on-site in our facility in Switzerland. We deliver our products from a few grams up to several tens of kg worldwide. Trust builds on quality and expertise – PeptART – Your Swiss pARTner in Peptide Chemistry.

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Novigenix is a Swiss precision medicine company specialized in ImmunoTranscriptomic solutions for the detection of disease, therapy optimization, and disease recurrence monitoring to improve disease management and patient outcomes.

LubioScience is the biggest lifescience reagents & services platform in Switzerland. Representing some of the world’s most recognized brands, we provide over 5 million products from more than 120 suppliers and pride ourselves in working with most Swiss biotech companies & start-ups.

Lunaphore has developed an innovative device for cancer tissue diagnostics. Its award-winning technology based on microfluidics aims to achieve faster & more precise results than current techniques. It was founded in 2004 with the vision of bringing –omics like approaches to tissue diagnostics. Lunaphor

Life Technologies Group develops and markets instrument-based systems, reagents, software, and contract services to the life science industry and research community.

Legacy Healthcare aims to develop novel drugs for autoimmune, inflammatory and aging-related conditions, safe enough for chronic use especially by fragile populations, e.g. children, cancer patients and the elderly, who may be already on multiple medications.

The purpose of Idorsia is to discover, develop and bring more, innovative medicines to patients. We have more ideas, we see more opportunities and we want to help more patients.

Helsinn is a global pharmaceutical company that builds, manufactures, launches, and commercializes products to improve the quality of life for patients with cancer and chronic disease, with a focus on supportive care, oncology and dermato-oncology.

Genedata transforms biopharma data into intelligence by combining deep science, technology, and AI domain knowledge. From early discovery to the clinic, the Genedata Biopharma Platform digitalizes and automates complex data workflows, driving innovation and data-based decisions to maximize ROI.

GMT Fine Chemicals SA is a Swiss company founded in 1998 based in Couvet (Neuchâtel). The company has been designed to allow the chemical synthesis of Active Pharmaceutical Ingredients (API) under conditions guaranteeing the quality of the products (GMP). Products are sold world-wide (EU, USA, JPN).

Future Health Pharma GmbH represents companies in Switzerland and distributes and markets their products in CH, UK and EU. We act as Marketing Authorisation Holder or establish their affiliate in CH and EU. We also hold an establishment license to handle controlled substances (narcotics) & vaccines.

evitria specializes in CHO-based transient expression of recombinant proteins, with a focus on antibodies—including bispecific, Fc-silenced, and afucosylated formats. With over 100,000 transfections, we are a trusted partner for biotech and pharma worldwide.

CSL (ASX:CSL; USOTC:CSLLY) – including our three businesses: CSL Behring, CSL Seqirus and CSL Vifor – is a global biotechnology leader that develops and delivers innovative lifesaving medicines, protects public health and helps people with life-threatening medical conditions live full lives.

Curatis acquires, licences, distributes and promotes pharmaceutical products for the treatment and/or prevention of rare and speciality diseases in Switzerland. We have a promising pipeline of novel speciality care and orphan drugs for neurological disorders.

Labcorp Central Laboratory Services helps pharmaceutical and biotech companies to develop new drugs by providing a full range of testing services, from preclinical investigations to conducting post-marketing studies. Services include toxicology studies and biostatistical analysis.

With over 40 years in the pharmaceutical industry, Cerbios is a privately held company headquartered in Barbengo‑Lugano, Switzerland, specialising in the development and manufacture of both chemical and biological APIs for its partners worldwide.

Bromatech has been engaged for more than 25 years in the study and development of targeted food supplements based on specific strains of lactic acid bacteria, antioxidants and essential fatty acids which are able to interact with the precious heritage of the human microbiota.

BÜHLMANN designs, develops, manufactures and sells worldwide innovative medical diagnostic products and kits (IVD or RUO) in inflammation, cellular allergy, neuroimmunology, clinical chemistry, chronobiology and others.

Securing life sciences supply chains. Complex chemicals, peptides and key biologics: products, services and innovation. Biosynth is a supplier of critical materials with chemicals on the milligram to ton scale, with peptides at mg to multikilogram scale. ISO 9001 and GMP facilities.

We at Bioengineering AG design and build customized equipment to improve bioproduction efficiency in biotech, novel food, and biopharma plants. Our engineering teams develop reliable bioreactors and fermenters, from lab scale to production, for clients worldwide. Trusted for over 50 years.

At Biogen, we develop, market and manufacture therapies for people living with serious neurological, autoimmune and rare diseases.

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN) is a commercial-stage biopharmaceutical company headquartered in Switzerland. Basilea is committed to discovering, developing and commercializing innovative drugs to meet the needs of patients with severe bacterial and fungal infections.

At BD, we are committed to sustainable healthcare. We are inspired by childhood to be innovative thinkers, to be ambitious in our ways of caring about the patients and healthcare professionals of tomorrow.

Bio-Rad Laboratories continues to play a leading role in the advancement of scientific discovery by offering a broad range of innovative tools and services to the life science research and clinical diagnostics markets.

Amphasys is a leading provider of label-free cell analysis solutions for cells from 1 to 250 um. Characteristics such as size, count and morphology, viability, metabolic and health status are determined real-time. Amphasys is market leader in pollen analysis in the seed industry.

AlveoliX provides in-vitro solutions based on proprietary and unique organ-on-chip technologies aimed at improving preclinical decision-making and thus reducing drug development costs.

Swiss health science co. pioneering clinically proven products to promote cellular health and longevity. The company’s proprietary nutrient, Mitopure, is clinically shown to combat age-related declines in mitochondrial health and muscle function. Nestlé Health Science is a global strategic partner.

ADIENNE is an integrated biopharmaceutical group of companies based in Lugano, Switzerland, with a proprietary portfolio of orphan-designated marketed medicinal product, clinical and preclinical product candidates focusing on critical conditions of high unmet medical needs.